HomeTENX • NASDAQ
add
Tenax Therapeutics Inc
Previous close
$13.10
Day range
$12.75 - $13.66
Year range
$4.64 - $14.16
Market cap
82.05M USD
Avg Volume
166.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.81M | 263.84% |
Net income | -15.80M | -298.99% |
Net profit margin | — | — |
Earnings per share | -0.40 | -110.53% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 99.37M | 1.08% |
Total assets | 102.81M | 3.03% |
Total liabilities | 6.60M | 157.60% |
Total equity | 96.21M | — |
Shares outstanding | 40.57M | — |
Price to book | 5.48 | — |
Return on assets | -40.27% | — |
Return on capital | -42.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -15.80M | -298.99% |
Cash from operations | -9.16M | -196.57% |
Cash from investing | — | — |
Cash from financing | 3.06M | -96.67% |
Net change in cash | -6.09M | -106.85% |
Free cash flow | -3.85M | -90.97% |
About
Founded
1967
Website
Employees
5
